The National Institute for Health Research (NIHR) is the nation’s largest funder of health research and offer support to NHS Trusts, researchers, universities and any other organisation conducting clinical research.
A recent report shows that the support given by the NIHR via their Clinical Research Networks (CRN) generated an estimated £8 billion of gross value added (GVA) to the NHS, over the last 3 years. The support also generated 47,467 full time equivalent jobs for the UK.
Other key findings from the report include:
Over the three year period (financial years) 2016/17 to 2018/19:
- The estimated annual economic contribution of NIHR CRN supported studies increased by £0.1 billion (GVA) between 2016/17 and 2018/19 (up from £2.6 billion in financial year 2016/17, to £2.7 billion in financial year 2018/19) – linked to increased commercial contract research activity supported by the NIHR CRN
- For each patient recruited onto a commercially-funded trial supported by the NIHR CRN, on average NHS providers in England received an estimated £9,200 from life sciences companies, and on average saved an estimated £5,800 per patient (where trial drugs replaced the standard treatment)
- The number of studies and patients recruited onto NIHR CRN supported studies have both increased by approximately 30% in three years (financial year 2016/17 – financial year 2018/19)
There was also a cost saving to the NHS of £28.6 million where trial drugs were provided and use in place of standard drugs.
As taken from the article, Matt Cooper, Business Development and Marketing Director at the NIHR Clinical Research Network said:
“The benefits to the UK of a strong and productive NIHR Clinical Research Network, working in partnership with the NHS, are clearly demonstrated in this report. It describes sustained growth in the Clinical Research Network Portfolio of both clinical research and its value to the UK economy – £2.7billion in 2018/19, an increase of £300million from the previous report in 2016.”